e-learning
resources
Paris 2018
Sunday, 16.09.2018
Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
H. Kang (Seoul, Republic of Korea), I. Kim (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
Source:
International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Session:
Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Session type:
Poster Discussion
Number:
428
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Kang (Seoul, Republic of Korea), I. Kim (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea). Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model. 428
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
The effect of pravastatin on bleomycin-induced lung injury and fibrosis in mouse
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury
Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant
Year: 2011
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation
versus
fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006
Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats
Source: Eur Respir J 2001; 17: 1228-1235
Year: 2001
Oxidative stress and lung permeability during chlorine-induced acute lung injury in mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
The role of osteopontin in the pulmonary fibrosis caused by acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011
The role of pendrin in acute lung injury caused by ventilator-induced lung injury
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Rikkunshito ameliorates bleomycin-induced lung injury in mice
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats
Source: Annual Congress 2007 - Respiratory pathophysiology
Year: 2007
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats
Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care
Year: 2011
Thymosin beta4 protects mice from bleomycin-induced damage in the lung
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept